Jump Financial’s Curanex Pharmaceuticals CURX Stock Holding History

Jump Financial’s Portfolio CURX Stock Details CURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.39K	Sell	10,551 -6,900	-40%	-$2.59K	﹤0.01%	1812
2025 Q4	$5.78K	Sell	17,451 -9,749	-36%	-$5.36K	﹤0.01%	1891
2025 Q3	$19.6K	Buy	+27,200	New	+$123K	﹤0.01%	1714

Other funds holding CURX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jump Financial's CURX Position: Q1 2026 in Review

Jump Financial reduced its Curanex Pharmaceuticals (CURX) stake by 40% in Q1 2026, selling an estimated $2.59K and leaving 10,551 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Jump Financial first reported a position in CURX in Q3 2025 and has held it in 3 quarters since. The position peaked at $19.6K in Q3 2025. 8 funds tracked by Wall St. Rank hold CURX as of Q1 2026.

Jump Financial held 10,551 shares of Curanex Pharmaceuticals worth $5.39K as of Q1 2026.
Jump Financial sold 6,900 Curanex Pharmaceuticals shares in Q1 2026, an estimated $2.59K.
Curanex Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1812 holding.
Jump Financial first reported a position in Curanex Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
Jump Financial's Curanex Pharmaceuticals position peaked at $19.6K in Q3 2025.
8 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.